Stuart Therapeutics, Inc.
PrivateLast Round
Series A
Mar 19, 2021
Total Funding Raised
$11M
Company Overview
Stuart Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops a synthesized peptide therapeutic platform intended to repair disease-damaged helical collagen in the eye.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stuart Therapeutics, Inc. Comps
Public and private peers based on sector, stage, and business model.
Stuart Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 19, 2021 |
Key People
Founding team and executive leadership
Stuart Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioBrit | Series A |
| Wisconsin Alumni Research Foundation | Series A |
| InFocus Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors increased 32% MoM, reaching 1.3K.
- Mar 19, 2021
$11M round led by InFocus Capital Partners.
Stuart Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Stuart Therapeutics, Inc.'s valuation, stock price, and market status.
